Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced the appointment of...
Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, announced the appointment of Kathy Bergsteinsson, MBA,...
In order to develop and create novel biological systems with distinctive functionalities, synthetic biology has arisen as a potent science that blends biology, genetics,...
Codagenix Inc., a clinical-stage synthetic biology company with a rational virus design platform for viral vaccines and immuno-oncology therapeutics, announced the presentation of preclinical...
HebeCell Corp, a biotechnology company developing ProtoNK cell therapeutics based on its proprietary 3D PSC-NK manufacture platform, and Logomix Inc, a Tokyo-based synthetic biology...